bioRxivCancer Biology
Multi-omics profiling of U2AF1 mutants dissects pathogenic mechanisms affecting RNA granules in myeloid malignancies
G. Biancon, P. Joshi, J. T. Zimmer, T. Hunck, Y. Gao, M. D. Lessard, E. Courchaine, A. E. Barentine, M. Machyna, V. Botti, A. Qin, R. Gbyli, A. Patel, Y. Song, L. Kiefer, G. Viero, N. Neuenkirchen, H. Lin, J. Bewersdorf, M. D. Simon, K. M. Neugebauer, T. Tebaldi, S. Halene
Abstract
Somatic mutations in splicing factors are of significant interest in myeloid malignancies and other cancers. U2AF1, together with U2AF2, is essential for 3 splice site recognition. U2AF1 mutations result in aberrant splicing, but the molecular mechanism and the full spectrum of consequences on RNA biology have not been fully elucidated to date. We performed multi-omics profiling of in vivo RNA binding, splicing and turnover for U2AF1 S34F and Q157R mutants. We dissected specific binding signals of U2AF1 and U2AF2 and showed that U2AF1 mutations individually alter U2AF1-RNA binding, resulting in defective U2AF2 recruitment. We demonstrated a complex relationship between differential binding and splicing, expanding upon the currently accepted loss-of-binding model. Finally, we observed that U2AF1 mutations increase the formation of stress granules in both cell lines and primary acute myeloid leukemia samples. Our results uncover U2AF1 mutation-dependent pathogenic RNA mechanisms and provide the basis for developing targeted therapeutic strategies.
- organism: human
- assay: bulk RNA-seq
- research focus: cell type annotation
- research focus: differential expression
- research focus: gene regulatory network inference
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- U2AF1 mutations alter splice site recognition in hematological malignancies
Janine O Ilagan, Aravind Ramakrishnan, … Robert K Bradley·bioRxiv·Sep 29, 2014
- The splicing factor U2AF1 contributes to cancer progression through a non-canonical role in translation regulation
M. Palangat, D. Anastsakis, … D. Larson·bioRxiv·Jul 18, 2018
- A Splice Site-Sensing Conformational Switch in U2AF2 is Modulated by U2AF1 and its Recurrent Myelodysplasia-Associated Mutation
C. L. Kielkopf, D. N. Ermolenko, … C. Warnasooriya·bioRxiv·Dec 31, 2019
- Wild-type U2AF1 antagonizes the splicing program characteristic of U2AF1-mutant tumors and is required for cell survival
Dennis Liang Fei, Hayley Motowski, … Harold Varmus·bioRxiv·Aug 24, 2016
- U2AF1 is a haplo-essential gene required for cancer cell survival
B. A. Wadugu, A. Heard, … M. J. Walter·Journal of Clinical InvestigationPeer-reviewed·Nov 1, 2021
- U2AF1 mutations rescue deleterious exon skipping induced by KRAS mutations
David M. Walter, Katherine Cho, … Matthew M. Meyerson·Nature GeneticsPeer-reviewed·Jul 1, 2026